390 related articles for article (PubMed ID: 31477055)
21. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.
Lawn SD; Harries AD; Meintjes G; Getahun H; Havlir DV; Wood R
AIDS; 2012 Nov; 26(17):2121-33. PubMed ID: 22695302
[TBL] [Abstract][Full Text] [Related]
22. Timing of initiation of antiretroviral drugs during tuberculosis therapy.
Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray A; Gengiah T; Nair G; Bamber S; Singh A; Khan M; Pienaar J; El-Sadr W; Friedland G; Abdool Karim Q
N Engl J Med; 2010 Feb; 362(8):697-706. PubMed ID: 20181971
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic study.
Ali SA; Mavundla TR; Fantu R; Awoke T
BMC Infect Dis; 2016 Nov; 16(1):640. PubMed ID: 27814693
[TBL] [Abstract][Full Text] [Related]
24. Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
Tanue EA; Nsagha DS; Njamen TN; Assob NJC
PLoS One; 2019; 14(7):e0218800. PubMed ID: 31361755
[TBL] [Abstract][Full Text] [Related]
25. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
Azeez A; Mutambayi R; Odeyemi A; Ndege J
Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
[TBL] [Abstract][Full Text] [Related]
26. Mortality among tuberculosis patients in the Democratic Republic of Congo.
Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
[TBL] [Abstract][Full Text] [Related]
27. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.
da Silva Escada RO; Velasque L; Ribeiro SR; Cardoso SW; Marins LMS; Grinsztejn E; da Silva Lourenço MC; Grinsztejn B; Veloso VG
BMC Infect Dis; 2017 May; 17(1):373. PubMed ID: 28558689
[TBL] [Abstract][Full Text] [Related]
28. Incidence and predictors of tuberculosis among children receiving antiretroviral therapy in the Wolaita Zone: A retrospective cohort study.
Tekese D; Dawit D; Hawulte B; Mohammed H; Asefa F; Oljira L
PLoS One; 2023; 18(9):e0291502. PubMed ID: 37733689
[TBL] [Abstract][Full Text] [Related]
29. Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
Siika AM; Yiannoutsos CT; Wools-Kaloustian KK; Musick BS; Mwangi AW; Diero LO; Kimaiyo SN; Tierney WM; Carter JE
PLoS One; 2013; 8(1):e53022. PubMed ID: 23301015
[TBL] [Abstract][Full Text] [Related]
30. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Miro JM; Vassilenko A; Girardi E; Bruyand M; Obel N; Lundgren JD; Mocroft A; Kirk O;
Lancet HIV; 2016 Mar; 3(3):e120-31. PubMed ID: 26939735
[TBL] [Abstract][Full Text] [Related]
31. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
[TBL] [Abstract][Full Text] [Related]
32. [Simultaneous treatment of HIV and tuberculosis is possible and necessary].
von der Maase S; Gerstoft J; Wejse C
Ugeskr Laeger; 2014 Feb; 176(6A):V03130163. PubMed ID: 25347439
[TBL] [Abstract][Full Text] [Related]
33. Half-life time prediction of developing first-line antiretroviral treatment failure and its risk factors among TB and HIV co-infected children in Northwest Ethiopia; multi setting historical follow-up study.
Chanie ES; Muche AA; Gobeza MB; Alemu EM; Addis WD; Azanaw MM; Gebremariam AD; Tesfa D; Engidaw MT; Atikilit G; AbebawTiruneh S; Arage G
BMC Pediatr; 2022 Mar; 22(1):114. PubMed ID: 35241036
[TBL] [Abstract][Full Text] [Related]
34. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
Harries AD; Zachariah R; Lawn SD
Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
[TBL] [Abstract][Full Text] [Related]
35. Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment.
Sinha S; Shekhar RC; Singh G; Shah N; Ahmad H; Kumar N; Sharma SK; Samantaray JC; Ranjan S; Ekka M; Sreenivas V; Mitsuyasu RT
BMC Infect Dis; 2012 Jul; 12():168. PubMed ID: 22846195
[TBL] [Abstract][Full Text] [Related]
36. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
[TBL] [Abstract][Full Text] [Related]
37. When to start antiretroviral therapy during tuberculosis treatment?
Naidoo K; Baxter C; Abdool Karim SS
Curr Opin Infect Dis; 2013 Feb; 26(1):35-42. PubMed ID: 23188213
[TBL] [Abstract][Full Text] [Related]
38. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
Havlir DV; Kendall MA; Ive P; Kumwenda J; Swindells S; Qasba SS; Luetkemeyer AF; Hogg E; Rooney JF; Wu X; Hosseinipour MC; Lalloo U; Veloso VG; Some FF; Kumarasamy N; Padayatchi N; Santos BR; Reid S; Hakim J; Mohapi L; Mugyenyi P; Sanchez J; Lama JR; Pape JW; Sanchez A; Asmelash A; Moko E; Sawe F; Andersen J; Sanne I;
N Engl J Med; 2011 Oct; 365(16):1482-91. PubMed ID: 22010914
[TBL] [Abstract][Full Text] [Related]
39. The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
Yang CH; Chen KJ; Tsai JJ; Lin YH; Cheng SH; Wang KF; Chiou HY
BMC Infect Dis; 2014 Jun; 14():304. PubMed ID: 24897928
[TBL] [Abstract][Full Text] [Related]
40. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
